Home » Stocks » QLI

Qilian International Holding Group Limited (QLI)

Stock Price: $8.75 USD -0.54 (-5.81%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $8.89 +0.14 (1.60%) Jan 15, 7:59 PM
Market Cap 306.25M
Revenue (ttm) 46.70M
Net Income (ttm) 5.07M
Shares Out 35.00M
EPS (ttm) 0.14
PE Ratio 60.43
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $8.75
Previous Close $9.29
Change ($) -0.54
Change (%) -5.81%
Day's Open 10.14
Day's Range 8.62 - 10.95
Day's Volume 3,157,215
52-Week Range 8.62 - 12.02

News

Hide News
GlobeNewsWire - 2 days ago

Jiuquan, China, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”) (Nasdaq: QLI), a China-based pharmaceutical and chemical products manufacturer, tod...

InvestorPlace - 4 days ago

Qilian (QLI) is catching the eyes of investors on Tuesday as shares of its stock started trading today via the company's IPO. The post Qilian IPO: 10 Things for Potential QLI Stock Investors t...

GlobeNewsWire - 4 days ago

Jiuquan, China, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Qilian International Holding Group Limited (the “Company”), a China-based pharmaceutical and chemical products manufacturer, today announced t...

About QLI

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivative (TCMD) products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licor... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Jan 12, 2021
CEO
Zhanchang Xin
Employees
279
Stock Exchange
NASDAQ
Ticker Symbol
QLI
Full Company Profile

Financial Performance

In 2019, QLI's revenue was $46.10 million, a decrease of -8.48% compared to the previous year's $50.37 million. Earnings were $5.33 million, an increase of 3.15%.

Financial Statements